Technical Analysis for NTUS - Natus Medical Incorporated

Grade Last Price % Change Price Change
B 27.49 -0.33% -0.09
NTUS closed down 0.33 percent on Friday, June 11, 2021, on 78 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical NTUS trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Stochastic Reached Overbought Strength -0.33%
Overbought Stochastic Strength -0.33%
MACD Bullish Signal Line Cross Bullish -0.97%
BB Squeeze Ended Range Expansion -0.97%
Up 3 Days in a Row Strength -0.97%
50 DMA Support Bullish 0.51%
Older End-of-Day Signals for NTUS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Natus Medical Incorporated Description

Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diseases Eye Clinics Disorders Injury Dysfunction Urology Hearing Healthcare Products Healthcare Product Epilepsy Neurology Public Health Retina Software System Nursing Software Systems Sleep Disorders Audiology Hearing Loss Infancy Intensive Care Medicine Surgical Treatment Assessment Products Live Streaming Brain Injury Electroencephalography Neonatology Nicu Diagnostic Systems Nervous Systems Neuromuscular Disease Streaming Video Balance Disorders Intensive Care Unit Neonatal Intensive Care Unit

Is NTUS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.88
52 Week Low 16.375
Average Volume 168,053
200-Day Moving Average 23.02
50-Day Moving Average 26.90
20-Day Moving Average 27.10
10-Day Moving Average 27.14
Average True Range 0.93
ADX 10.65
+DI 20.96
-DI 14.99
Chandelier Exit (Long, 3 ATRs) 25.79
Chandelier Exit (Short, 3 ATRs) 28.53
Upper Bollinger Bands 28.13
Lower Bollinger Band 26.08
Percent B (%b) 0.69
BandWidth 7.54
MACD Line 0.16
MACD Signal Line 0.10
MACD Histogram 0.0527
Fundamentals Value
Market Cap 931.02 Million
Num Shares 33.9 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -21.34
Price-to-Sales 1.61
Price-to-Book 1.76
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.39
Resistance 3 (R3) 28.43 28.16 28.24
Resistance 2 (R2) 28.16 27.93 28.15 28.19
Resistance 1 (R1) 27.83 27.79 27.70 27.79 28.14
Pivot Point 27.56 27.56 27.50 27.55 27.56
Support 1 (S1) 27.23 27.33 27.10 27.19 26.84
Support 2 (S2) 26.96 27.19 26.95 26.79
Support 3 (S3) 26.63 26.96 26.74
Support 4 (S4) 26.59